It inhibited the phosphorylation of Akt, mechanistic target of rapamycin (mTOR), rS6, and ErbB3 binding protein 1 in breast cancer cells, suggesting a link between the Akt/mTOR signaling pathway and mitochondrial function in the context of breast cancer (77). Here, PA2G4 is linked to breast cancer.